Brief: Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
05/10/2023 21:37
Oct 5 (Reuters) - Blueprint Medicines Corp BPMC.O :
* BLUEPRINT MEDICINES ANNOUNCES INDUCEMENT GRANTS UNDER
NASDAQ
LISTING RULE 5635(C)(4)
Source text for Eikon: ID:nPn7MNJ8ka
Further company coverage: BPMC.O
((Reuters.briefs@thomsonreuters.com;))
Recent news on Blueprint Medicines
See all newsBrief: Sanofi Announces Extension Of Blueprint Tender Offer
Brief: Blueprint Medicines Announces Data Reinforcing Safety Profile Of Long-Term Ayvakit
U.S. STOCKS ON THE MOVE-Texas Instruments, Broadcom, Circle
UBS raises Blueprint Medicines' PT on Sanofi's up to $9.5 billion takeover deal
U.S. RESEARCH ROUNDUP-Biomea Fusion, GE Aerospace, P&G